Evidence-based management options for women at increased breast/ovarian cancer risk

被引：28

作者：

Pichert, G ^{[1
]}

Bolliger, B ^{[1
]}

Buser, K ^{[1
]}

Pagani, O ^{[1
]}

机构：

[1] Univ Hosp, Dept Med, Div Oncol, Zurich, Switzerland

来源：

ANNALS OF ONCOLOGY | 2003年 / 14卷 / 01期

关键词：

BRCA1; BRCA2; familial risk; hereditary breast cancer; ovarian cancer; prophylactic surgery;

D O I：

10.1093/annonc/mdg030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recent developments in our ability to predict breast cancer risk necessitates primary care physicians learn to evaluate breast cancer risk and its importance in shaping decisions concerning surveillance and risk reduction measures. This article reviews the current opinion on risk assessment and management of women with an increased risk of breast/ovarian cancer. Management options are given for women at slightly, moderately and highly elevated breast cancer risk, as well as for BRCA 1/2 carriers, based on currently available evidence.

引用

收藏

页码：9 / 19

页数：11

相关论文

共 103 条

[1] OSTEOPOROSIS AFTER OOPHORECTOMY FOR NON-MALIGNANT DISEASE IN PREMENOPAUSAL WOMEN [J].

AITKEN, JM ;

HART, DM ;

ANDERSON, JB ;

LINDSAY, R ;

SMITH, DA ;

SPEIRS, CF .

BRITISH MEDICAL JOURNAL, 1973, 2 (5862) :325-328

[2]

[Anonymous], 1995, JAMA, V273, P491

[3] Assessing the risk of breast cancer. [J].

Armstrong, K ;

Eisen, A ;

Weber, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) :564-571

[4] A genetic epidemiological study of carcinoma of the fallopian tube [J].

Aziz, S ;

Kuperstein, G ;

Rosen, B ;

Cole, D ;

Nedelcu, R ;

McLaughlin, J ;

Narod, SA .

GYNECOLOGIC ONCOLOGY, 2001, 80 (03) :341-345

[5]

Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0

[6] BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes [J].

Berry, DA ;

Iversen, ES ;

Gudbjartsson, DF ;

Hiller, EH ;

Garber, JE ;

Peshkin, BN ;

Lerman, C ;

Watson, P ;

Lynch, HT ;

Hilsenbeck, SG ;

Rubinstein, WS ;

Hughes, KS ;

Parmigiani, G .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2701-2712

[7] Findings from 752081 clinical breast examinations reported to a national screening program from 1995 through 1998 [J].

Bobo, JK ;

Lee, NC ;

Thames, SF .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (12) :971-976

[8] VALIDATION OF A BREAST-CANCER RISK ASSESSMENT MODEL IN WOMEN WITH A POSITIVE FAMILY HISTORY [J].

BONDY, ML ;

LUSTBADER, ED ;

HALABI, S ;

ROSS, E ;

VOGEL, VG .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (08) :620-625

[9] CAN OVARIAN MASSES BE CHARACTERIZED USING ULTRASOUND [J].

BOURNE, T .

GYNECOLOGIC ONCOLOGY, 1993, 51 (01) :4-6

[10] Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].

Brekelmans, CTM ;

Seynaeve, C ;

Bartels, CCM ;

Tilanus-Linthorst, MMA ;

Meijers-Heijboer, EJ ;

Crepin, CMG ;

van Geel, AN ;

Menke, M ;

Verhoog, LC ;

van den Ouweland, A ;

Obdeijn, IM ;

Klijn, JGM .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930

← 1 2 3 4 5 6 7 8 9 10 →